Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain 4Prostatic Neoplasms 3Carcinoma, Hepatocellular 3Pain, Postoperative 2Lung Neoplasms 2Inflammation 2Stomach Neoplasms 1Postoperative Nausea and Vomiting 1Pancreatic Neoplasms 1Neuroma, Acoustic 1Neoplasms 1Melanoma 1Liver Neoplasms 1Liver Diseases 1Gynecological Laparoscopic Surgery 1Esophageal Neoplasms 1Emergence Delirium 1Chronic Pain 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Dexamethasone 5ramosetron 3Ondansetron 2Calcium Dobesilate 2Acupuncture Therapy 2phenazine 1esmolol 1Therapeutics 1Surveys and Questionnaires 1Sufentanil 1Promethazine 1Postoperative Care 1Olanzapine 1Gelatin 1Fentanyl 1Famotidine 1Electroacupuncture 1Electric Stimulation Therapy 1Electric Stimulation 1Diphenhydramine 1Dexmedetomidine 1Aprepitant 1Antiemetics 1Anesthesia, General 1Anesthesia 1Adrenergic beta-Antagonists 1((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Postoperative Nausea and Vomiting × Sufentanil × Clear all
NCT07479446 2026-05-22

Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

Xuanwu Hospital, Beijing

Phase NA Recruiting
174 enrolled
CNS

Neuroma, Acoustic, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡